CPHI & PMEC China 2023 to see surge from pent up international ingredients demand
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
The committee voted that FDA should restrict use of LYNPARZA plus abi/pred to these BRCAm mCRPC patients
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
Super-Bond is made up of a polymerization initiator, a liquid and a polymer powder
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
Net profit for FY23 at Rs. 140 crore as compared to Rs. 166 crore in FY22
Specialty Chemicals grew 38% YoY for FY23
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
Subscribe To Our Newsletter & Stay Updated